Hainan Shuangcheng Pharmaceuticals Co Ltd Class A 002693
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- CNY 6.11
- Day Range
- CNY 5.63–5.94
- 52-Week Range
- CNY 3.67–9.72
- Bid/Ask
- CNY 5.64 / CNY 5.65
- Market Cap
- CNY 2.35 Bil
- Volume/Avg
- 28.2 Mil / 16.6 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 13.14
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Hainan Shuangcheng Pharmaceuticals Co Ltd is engaged in the research, development, and sales of synthesized peptide drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 474
- Website
- http://www.shuangchengmed.com
Comparables
Valuation
Metric
|
002693
|
300016
|
000915
|
---|---|---|---|
Price/Earnings (Normalized) | — | — | 14.59 |
Price/Book Value | 5.50 | 1.61 | 2.68 |
Price/Sales | 13.14 | 2.91 | 3.38 |
Price/Cash Flow | 328.78 | 45.63 | 7.90 |
Price/Earnings
002693
300016
000915
Financial Strength
Metric
|
002693
|
300016
|
000915
|
---|---|---|---|
Quick Ratio | 0.44 | 2.84 | — |
Current Ratio | 0.74 | 3.76 | — |
Interest Coverage | −0.28 | −0.39 | — |
Quick Ratio
002693
300016
000915
Profitability
Metric
|
002693
|
300016
|
000915
|
---|---|---|---|
Return on Assets (Normalized) | −4.75% | −2.34% | 11.61% |
Return on Equity (Normalized) | −8.05% | −3.88% | 20.00% |
Return on Invested Capital (Normalized) | −4.32% | −1.18% | 13.38% |
Return on Assets
002693
300016
000915
Drug Manufacturers - Specialty & Generic Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Nkzrkbqj | Bfdbc | $76.9 Bil | |
MKKGY
| Merck KGaA ADR | Nlmkbsdv | Zckbnpl | $72.0 Bil | |
HLN
| Haleon PLC ADR | Swpdxmh | Gfvk | $37.5 Bil | |
TEVA
| Teva Pharmaceutical Industries Ltd ADR | Lhbtszjft | Zgvpm | $17.9 Bil | |
VTRS
| Viatris Inc | Cjnkywh | Vcwsz | $13.4 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Jgwccws | Fkfml | $11.7 Bil | |
CTLT
| Catalent Inc | Gykhsvfjr | Ggqzqn | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Dkyztznz | Yqlv | $4.2 Bil | |
CURLF
| Curaleaf Holdings Inc | Fnhggdsv | Lksp | $4.0 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Jjtwrpr | Pjrqffc | $3.5 Bil |